The need for novel biomarkers in prostate cancer: a UrOP perspective.

IF 1.3 Q3 UROLOGY & NEPHROLOGY

Archivio Italiano di Urologia e Andrologia Pub Date : 2025-09-30 Epub Date: 2025-09-11 DOI:10.4081/aiua.2025.14279

Guglielmo Mantica, Stefano Alba, Andrea Alfarone, Umberto Capitanio, Donato Dente, Carlo Giulioni, Carmelo Morana, Serena Maruccia, Gabriella Mirabile, Gennaro Musi, Mauro Ragonese, Mauro Silvani, Antonio Tufano, Angelo Cafarelli, Alessandro Calarco, Ottavio De Cobelli, Ferdinando De Marco, Giovanni Ferrari, Giuseppe Mario Ludovico, Stefano Pecoraro, Domenico Tuzzolo, Renzo Colombo, Nazareno Suardi, Rosario Leonardi

引用次数: 0

Abstract

Dear Editor, Prostate cancer (PCa) remains one of the most common malignancies among men worldwide, representing a major healthcare burden both in terms of morbidity and economic cost...

查看原文本刊更多论文

前列腺癌需要新的生物标志物：UrOP的观点。

亲爱的编辑，前列腺癌（PCa）仍然是世界范围内男性最常见的恶性肿瘤之一，在发病率和经济成本方面都是一个主要的医疗负担…

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊